GW842166
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for GW842166, covering 2009-05-18 to 2017-07-11. Get the full timeline:
Most recent: Clinical Trial Update: A Study Of The Effects Of CB2 Compound Of GW842166 In Patients With Osteoarthritis [Phase 2]